Clinical Trial Update: Allofit® IT With HXPE in Total Hip Arthroplasty

View source ↗

Summary

A clinical trial evaluating Allofit IT with HXPE in total hip arthroplasty has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis
• Inflammatory Arthritis
• Osteoarthritis of the Hip
• Post-traumatic Osteoarthritis of the Hip

Drugs mentioned

• Allofit IT with HXPE

Snippet

Sponsor: Zimmer Biomet | Conditions: Avascular Necrosis, Osteoarthritis, Hip | Status: COMPLETED | Results posted: 2026-01-27